Full length article| Volume 210, P242-246, March 2017

Download started.


Amino acid chelated iron versus an iron salt in the treatment of iron deficiency anemia with pregnancy: A randomized controlled study

Published:January 03, 2017DOI:



      The aim of this study was to compare the efficacy and tolerability of iron amino acid chelate (IAAC) and ferrous fumarate (FF) in treatment of iron deficiency anemia (IDA) with pregnancy.

      Study design

      A total of 150 pregnant women having iron deficiency anemia (IDA) were randomized to receive either IAAC or FF for 12 weeks. Hemoglobin, red cell indices, serum iron, and serum ferritin were measured at baseline and then 4, 8, and 12 weeks after treatment. Adverse effects were questioned in both groups.


      The mean values of hemoglobin, red cell indices, serum iron, and serum ferritin were not significantly different between both groups after 12 weeks of treatment. However, the rise in hemoglobin level after 4, 8, and 12 weeks of treatment was significantly faster in the IAAC group (p = <0.001). Constipation and abdominal colicky pain were significantly more common in the FF group (p = 0.022 and 0.031 respectively).


      IAAC and FF are comparable in curing IDA with pregnancy; however, IAAC has the advantage of providing a faster rate of improvement of hemoglobin level and is better tolerated by the patients.


      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


        • World Health Organization
        The prevalence of anemia in women: a tabulation of available information.
        WHO, Maternal Health and Safe Motherhood Programme, Division of Family Health. 2nd edition. WHO, Geneva, Switzerland1992
        • Osborne P.T.
        • Burkett L.L.
        • Ryan G.M.
        • Lane M.
        An evaluation of red blood cell heterogeneity (increased red blood cell distribution width) in iron deficiency of pregnancy.
        Am J Obstet Gynecol. 1989; 160: 336-339
        • World Health Organization
        Worldwide prevalence of anemia 1993–2005.
        WHO Global Database on anemia. WHO, Switzerland2008
        • Milman N.
        • Bergholt T.
        • Eriksen L.
        • Byg K.E.
        • Graudal N.
        • Pedersen P.
        • et al.
        Iron prophylaxis during pregnancy-how much iron is needed? A randomized dose- response study of 20–80 mg ferrous iron daily in pregnant women.
        Acta Obstet Gynecol Scand. 2005; 84: 238-247
        • Sharma J.B.
        Nutritional anemia during pregnancy in non-industrialized countries.
        in: Studd J. Progress in Obstetrics and Gynecology. Churchill Livingstone, New Delhi2003: 103-122
        • Lops V.R.
        • Hunter L.P.
        • Dixon L.R.
        Anemia in pregnancy.
        Am Fam Physician. 1995; 94: 277-280
        • Milman N.
        Iron and pregnancy-a delicate balance.
        Ann Hematol. 2006; 85: 559-565
        • Bothwell T.H.
        Iron requirements in pregnancy and strategies to meet them.
        Am J Clin Nutr. 2000; 72: 257-264
      1. Nutritional anemias.
        Report of a World Health Organization Group of Experts (Technical Report Series No. 503). WHO, Geneva1972
        • Frewin R.
        • Henson A.
        • Provan D.
        ABC of clinical hematology: iron deficiency anemia.
        BMJ. 1997; 314: 360-363
        • Sharma N.
        Iron absorption: IPC therapy is superior to conventional iron salts.
        Obstet Gynecol. 2001; : 515-519
        • Galy B.
        • Ferring-Appel D.
        • Sauer S.W.
        • Kaden S.
        • Lyoumi S.
        • Puy H.
        • et al.
        Iron regulatory proteins secure mitochondrial iron sufficiency and function.
        Cell Metab. 2010; 12: 194-201
        • Burns D.
        Enhanced transport of amino acid chelated minerals.
        Research and Development. Seroyal Brands, Inc., Concord, California2002
        • Smita S.
        • Sukhija S.
        • Renu T.
        • Sagaonkar P.D.
        Pregnancy induced iron deficiency and the evaluation and comparison of the efficacy and safety of ferrous fumarate and carbonyl iron in its treatment-PERFECT trial.
        J Obstet Gynecol India. 2009; 59: 552-562
        • Milman N.
        Prepartum anemia: prevention and treatment.
        Ann Hematol. 2008; 87: 949-959
        • Pineda O.
        • Ashmead H.D.
        • Perez J.M.
        • Lemus C.P.
        Effectiveness of iron amino acid chelate on the treatment of iron deficiency anemia in adolescents.
        J Appl Nutr. 1994; 46: 2-13
        • Fouad M.T.
        Chelation and chelated minerals.
        J Appl Nutr. 1976; 28
        • Abdel-Lah M.A.
        • Rasheed S.M.
        • Hassan I.A.
        • El-sayed A.A.
        Iron chelated amino acid therapy versus oral iron therapy for the treatment of iron-deficiency anemia with pregnancy.
        J Egypt Soc Obstet Gynecol. 2006; 32: 419-428
        • Soliman G.Z.A.
        • Mahfouz M.H.
        • Emara I.A.
        Effect of different types of oral iron therapy used for the treatment of iron deficiency anemia and their effects on some hormones and minerals in anemic rats.
        J Am Sci. 2010; 6: 109-118
        • Kamdi S.P.
        • Palkar P.J.
        Efficacy and safety of ferrous asparto glycinate in the management of iron deficiency anaemia in pregnant women.
        J Obstet Gynecol. 2015; 35: 4-8
        • Fouad G.T.
        • Evans M.
        • Sharma P.
        • Baisley J.
        • Crowley D.
        • Guthrie N.
        A randomized, double-blind clinical study on the safety and tolerability of an iron multi-amino acid chelate preparation in premenopausal women.
        J Diet Suppl. 2013 Mar; 10: 17-28
        • Milman N.
        • Jønsson L.
        • Dyre P.
        • Pedersen P.L.
        • Larsen L.G.
        Ferrous bisglycinate 25 mg iron is as effective as ferrous sulfate 50 mg iron in the prophylaxis of iron deficiency and anemia during pregnancy in a randomized trial.
        J Perinat Med. 2014; 42: 197-206
        • Rojas M.L.
        • Sánchez J.
        • Villada Ó.
        • Montoya L.
        • Díaz A.
        • Vargas C.
        • et al.
        Effectiveness of iron amino acid chelate versus ferrous sulfate as part of a food complement in preschool children with iron deficiency.
        Biomedica. 2013; 33: 350-360